A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 16, 2021

Primary Completion Date

January 5, 2022

Study Completion Date

January 5, 2022

Conditions

Healthy Subjects

Interventions

DRUG

TS-142

DRUG

Zopiclone

DRUG

Placebo

Trial Locations (1)

Taisho Pharmaceutical Co., Ltd selected site, Tokyo

All Listed Sponsors

lead

Taisho Pharmaceutical Co., Ltd.

INDUSTRY

NCT04696952 - A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects | Biotech Hunter | Biotech Hunter